XML 36 R8.htm IDEA: XBRL DOCUMENT
v3.24.3

Expenses by nature | 9 Months Ended
--- | ---
Sep. 30, 2024
Expenses by nature [Abstract] |
Expenses by nature |
3. | Expenses by nature
The following table provides the consolidated statement of comprehensive income classification of our expense by nature:
|  | Three months ended September 30, |  |  | Nine months ended September 30, |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
|  | $’000 |  |  | $’000 |  |  | $’000 |  |  | $’000 |
External research and development expenses |  |  | 6,728 |  |  |  | 5,207 |  |  |  | 21,651 |  |  |  | 16,521 |
Employee expenses1, 3 |  |  | 1,606 |  |  |  | 1,812 |  |  |  | 4,964 |  |  |  | 4,857 |
Depreciation |  |  | 5 |  |  |  | 8 |  |  |  | 16 |  |  |  | 28 |
Other expenses |  |  | 58 |  |  |  | 61 |  |  |  | 179 |  |  |  | 164 |
Total research and development expenses |  |  | 8,397 |  |  |  | 7,088 |  |  |  | 26,810 |  |  |  | 21,570 |
External costs |  |  | 3,016 |  |  |  | 1,725 |  |  |  | 7,253 |  |  |  | 5,834 |
Employee expenses2, 3 |  |  | 1,134 |  |  |  | 834 |  |  |  | 3,084 |  |  |  | 2,450 |
Depreciation |  |  | 74 |  |  |  | 72 |  |  |  | 221 |  |  |  | 209 |
Total general and administrative expenses |  |  | 4,224 |  |  |  | 2,631 |  |  |  | 10,558 |  |  |  | 8,493 |
Total operating expenses |  |  | 12,621 |  |  |  | 9,719 |  |  |  | 37,368 |  |  |  | 30,063 |
1 Included in employee expenses is a share based compensation expense of $0.1 million and $0.2 million for the three and nine months ended September 30, 2024, respectively, relating to employees in the research and development department (three and nine months ended September 30, 2023, $0.4 million and $1.0 million, respectively). 2 Included in employee expenses is share based compensation expense of $0.1 million and $0.2 million for the three and nine months ended September 30, 2024, respectively, relating to employees in the general and administrative department (three and nine months ended September 30, 2023, $0.2 million and $0.7 million, respectively). 3 Includes termination expenses incurred in the nine months ended September 30, 2024. Foreign exchange gain/loss Foreign exchange loss of $1.8 million for the three months ended September 30, 2024 (gain of $1.8 million for the three months ended September 30, 2023), and foreign exchange loss of $0.1 million for the nine months ended September 30, 2024 (gain of $0.2 million for the nine months ended September 30, 2023) consists primarily of gains and losses related to the translation of the U.S. dollar cash and other financial assets balance into euro in the accounts of the Company’s subsidiary, GH Research Ireland Limited, whose functional currency is euro as explained in the Group’s consolidated financial statements for the year ended December 31, 2023. At September 30, 2024, if the U.S. dollar had weakened/strengthened by 10% against the euro with all other variables held constant, the loss before tax for the nine months ended September 30, 2024, would have been $3.4 million higher/lower, mainly related to the translation of cash and other financial assets held in U.S. dollar in the Company’s subsidiary, GH Research Ireland Limited. This would be offset by an equivalent amount within Other Comprehensive Income.

X
- Definition The disclosure of expenses by nature. [Refer: Expenses, by nature] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 10 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_10_e&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfExpensesByNatureExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_ExpenseByNatureAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration